首页 | 本学科首页   官方微博 | 高级检索  
     


Hepatitis C virus genotype 1: How genetic variability of the core protein affects the response to pegylated‐interferon and ribavirin therapy
Authors:F.S. Alhamlan  M.N. Al‐Ahdal  N.Z. Khalaf  A.A. Abdo  F.M. Sanai  H.I. Al‐Ashgar  M. ElHefnawi  A. Zaid  A.A. Al‐Qahtani
Affiliation:1. Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia;2. Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia;3. Liver Disease Research Center, King Saud University, Riyadh, Saudi Arabia;4. Section of Gastroenterology, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia;5. Hepatobiliary Sciences and Liver Transplantation, King Abdulaziz Medical City, Riyadh, Saudi Arabia;6. Department of Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia;7. Biomedical Informatics and Chemo Informatics Group, Informatics and Systems Department, National Research Centre, Cairo, Egypt;8. Scientific Institute and Research Academy (SIRA‐Corp), Cairo, Egypt;9. Molecular Diagnostics & Therapeutics Department, Genetic Engineering & Biotechnology Research Institute (GEBRI), Monofia University, Egypt
Abstract:
Keywords:hepatitis C virus  genotype 1  PEG‐IFN/RBV therapy  sustained virological response  Saudi Arabia
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号